These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8811383)

  • 21. Uterine sarcomas in breast cancer patients treated with tamoxifen.
    Arenas M; Rovirosa A; Hernández V; Ordi J; Jorcano S; Mellado B; Biete A
    Int J Gynecol Cancer; 2006; 16(2):861-5. PubMed ID: 16681774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: the effects of tamoxifen.
    Silva EG; Tornos CS; Follen-Mitchell M
    Int J Gynecol Pathol; 1994 Jul; 13(3):248-58. PubMed ID: 7928058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uterine müllerian adenosarcoma with sarcomatous overgrowth and lung metastasis in a 25-year-old woman.
    Choi YJ; Jung MH; Park YK; Lee BY; Huh CY
    Eur J Gynaecol Oncol; 2011; 32(1):91-4. PubMed ID: 21446335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer.
    Curtis RE; Freedman DM; Sherman ME; Fraumeni JF
    J Natl Cancer Inst; 2004 Jan; 96(1):70-4. PubMed ID: 14709741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uterine pleomorphic rhabdomyosarcoma in a patient receiving tamoxifen therapy.
    Okada DH; Rowland JB; Petrovic LM
    Gynecol Oncol; 1999 Dec; 75(3):509-13. PubMed ID: 10600318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mullerian adenosarcoma of the uterus associated with tamoxifen treatment for breast cancer.
    Ceylan Y; Doğer E; Çakıroğlu AY; Vural Ç; Yücesoy İ
    Turk J Obstet Gynecol; 2015 Dec; 12(4):244-247. PubMed ID: 28913077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uterine adenosarcoma in a patient with history of breast cancer and long-term tamoxifen consumption.
    Akhavan A; Akhavan Tafti M; Aghili F; Navabii H
    BMJ Case Rep; 2012 Oct; 2012():. PubMed ID: 23087268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Uterine adenosarcoma. Apropos of a case of uterine and vaginal adenosarcoma with a corrected genital prolapse].
    Kabwa L; Mattei JP; Eloit S; Ramadane A; Grange B
    J Chir (Paris); 1997 Jul; 134(2):80-5. PubMed ID: 9378790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological analysis of mullerian adenosarcoma of the uterus.
    Han XY; Xiang Y; Guo LN; Shen K; Wan XR; Huang HF; Pan LY
    Chin Med J (Engl); 2010 Mar; 123(6):756-9. PubMed ID: 20368100
    [No Abstract]   [Full Text] [Related]  

  • 30. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
    Mikami Y; Hata S; Kiyokawa T; Manabe T
    Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Müllerian adenosarcoma: a review of cases and literature.
    Huang PS; Chang WC; Huang SC
    Eur J Gynaecol Oncol; 2014; 35(6):617-20. PubMed ID: 25556263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cluster of uterine mullerian adenosarcoma in the Washington, DC metropolitan area with high incidence of sarcomatous overgrowth.
    Seidman JD; Wasserman CS; Aye LM; MacKoul PJ; O'Leary TJ
    Am J Surg Pathol; 1999 Jul; 23(7):809-14. PubMed ID: 10403304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mullerian adenosarcoma of the cervix: case report with conservative management].
    Teco-Cortes JA; Grube-Pagola P; Saldaña-Quiroz VA; Alderete-Vázquez G
    Cir Cir; 2018; 86(2):191-195. PubMed ID: 29809188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract.
    Friedlander ML; Covens A; Glasspool RM; Hilpert F; Kristensen G; Kwon S; Selle F; Small W; Witteveen E; Russell P
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S78-82. PubMed ID: 25341585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endometrial adenosarcoma with adjuvant tamoxifen therapy for primary breast carcinoma.
    Jagavkar RS; Shakespeare TP; Stevens MJ
    Australas Radiol; 1998 May; 42(2):157-8. PubMed ID: 9599835
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of uterine Müllerian adenosarcoma with extrauterine metastatic deposits.
    Guidozzi F; Smith T; Koller AB; Reinecke L
    Gynecol Oncol; 2000 Jun; 77(3):464-6. PubMed ID: 10831361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tamoxifen and endometrial pathology].
    Negoiţă M; Terinte C; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature review.
    Behtash N; Hashemi R; Karimi Zarchi M
    Asian Pac J Cancer Prev; 2009; 10(1):163-6. PubMed ID: 19469647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term tamoxifen treatment: a possible aetiological factor in the development of uterine carcinosarcoma: two case-reports and review of the literature.
    Fotiou S; Hatjieleftheriou G; Kyrousis G; Kokka F; Apostolikas N
    Anticancer Res; 2000; 20(3B):2015-20. PubMed ID: 10928144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas.
    Seidman JD; Chauhan S
    Int J Gynecol Pathol; 2003 Jan; 22(1):75-82. PubMed ID: 12496702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.